APA (7th ed.) Citation

Joon Hyung Kim, John Diaz-Decaro, Ning Jiang, Shinn-Jang Hwang, Eun Ju Choo, Maribel Co, . . . Anne Schuind. (2021). The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: A sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Joon Hyung Kim, et al. The Adjuvanted Recombinant Zoster Vaccine Is Efficacious and Safe in Asian Adults ≥ 50 Years of Age: A Sub-cohort Analysis of the ZOE-50 and ZOE-70 Randomized Trials. Taylor & Francis Group, 2021.

MLA (9th ed.) Citation

Joon Hyung Kim, et al. The Adjuvanted Recombinant Zoster Vaccine Is Efficacious and Safe in Asian Adults ≥ 50 Years of Age: A Sub-cohort Analysis of the ZOE-50 and ZOE-70 Randomized Trials. Taylor & Francis Group, 2021.